Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Pattengale

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|July 5, 1996
Structural requirements for the ectodomain cleavage of human cell surface macrophage colony-stimulating factorP Deng, C W Rettenmier, P K Pattengale
Blood|November 15, 1989
Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disordersG M Gersuk, R Carmel, P K Pattengale
The American Journal of Pathology|June 1, 1972
Fate of autogenous canine lymphocytes after injection into an afferent lymphatic of the popliteal lymph nodeP K Pattengale, W M Stahl, G J Thorbecke
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicityG M Gersuk, W C Chang, P K Pattengale
Natural Immunity and Cell Growth Regulation|January 1, 1991
Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factorW C Chang, M H Hsiao, P K Pattengale
Virology|September 1, 1988
Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequencesH Fan, H Chute, E Chao, et al.
Biochemistry|January 28, 1999
Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factorP Deng, Y L Wang, Y Haga, et al.
Molecular and Cellular Biology|May 1, 1989
Differentiation in vitro of a leukemia virus-induced B-cell lymphoma into macrophagesR Hanecak, D C Zovich, P K Pattengale, et al.
Virology|July 1, 1993
Specificity of disease induced by M-MuLV chimeric retroviruses containing v-myc or v-src is not determined by the LTRG Feuer, W T Lee, P K Pattengale, et al.
American Journal of Clinical Pathology|March 1, 1980
Direct tissue visualization of normal cross-reacting antigen in neoplastic granulocytesP K Pattengale, C R Taylor, E Engvall, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|July 5, 1996
Structural requirements for the ectodomain cleavage of human cell surface macrophage colony-stimulating factorP Deng, C W Rettenmier, P K Pattengale
Blood|November 15, 1989
Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disordersG M Gersuk, R Carmel, P K Pattengale
The American Journal of Pathology|June 1, 1972
Fate of autogenous canine lymphocytes after injection into an afferent lymphatic of the popliteal lymph nodeP K Pattengale, W M Stahl, G J Thorbecke
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicityG M Gersuk, W C Chang, P K Pattengale
Natural Immunity and Cell Growth Regulation|January 1, 1991
Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factorW C Chang, M H Hsiao, P K Pattengale
Virology|September 1, 1988
Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequencesH Fan, H Chute, E Chao, et al.
Biochemistry|January 28, 1999
Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factorP Deng, Y L Wang, Y Haga, et al.
Molecular and Cellular Biology|May 1, 1989
Differentiation in vitro of a leukemia virus-induced B-cell lymphoma into macrophagesR Hanecak, D C Zovich, P K Pattengale, et al.
Virology|July 1, 1993
Specificity of disease induced by M-MuLV chimeric retroviruses containing v-myc or v-src is not determined by the LTRG Feuer, W T Lee, P K Pattengale, et al.
American Journal of Clinical Pathology|March 1, 1980
Direct tissue visualization of normal cross-reacting antigen in neoplastic granulocytesP K Pattengale, C R Taylor, E Engvall, et al.
Pageof 7